Janney Montgomery Scott
INBX icon

Janney Montgomery Scott’s Inhibrx INBX Stock Holding History

Janney Montgomery Scott’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Buy
6,406
+911
+17% +$67.6K ﹤0.01% 2141
2025
Q4 		$434K Buy
+5,495
New +$374K ﹤0.01% 2299

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janney Montgomery Scott's INBX Position: Q1 2026 in Review

Janney Montgomery Scott increased its Inhibrx (INBX) stake by 17% in Q1 2026, buying an estimated $67.6K and bringing the position to 6,406 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Janney Montgomery Scott first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $434K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Janney Montgomery Scott held 6,406 shares of Inhibrx worth $431K as of Q1 2026.
  • Janney Montgomery Scott bought 911 Inhibrx shares in Q1 2026, an estimated $67.6K.
  • Inhibrx made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2141 holding.
  • Janney Montgomery Scott first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • Janney Montgomery Scott's Inhibrx position peaked at $434K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.